Incubator at North Brunswick Tenants
Celleqore
Celleqore, we know expertise and close collaboration are required to effectively conduct outsourced experiments, particularly in flow cytometry and cell-based assays.
We are a small business with more than 50 years of experience in the pharmaceutical, biotechnology, and manufacturing industries. Our commitment and dedication to advancing scientific innovation is unmatched and driven by our passion to improve human health.
Chrom-Matrix Inc.
Chrom-Matrix Inc. is an innovative chromatographic company primarily focused on the creation, development, manufacturing and supply of HPLC columns, sample preparation consumables, discovery methodology with outstanding performance for separation, analysis and purification of organic chemicals and biochemicals.
Couragene
Couragene.com
Couragene is leveraging its breakthrough delivery platforms to develop next-generation gene and biologic therapies. Couragene harnesses its innovative technologies to create novel therapeutics via non-viral delivery of genome editing machinery, DNA/RNA, and other biologics. Furthermore, Couragene has discovered and developed proprietary materials for oral delivery of therapeutic agents.
Delve Therapeutics
delvetx.com
Delve Therapeutics is a discovery-stage startup researching novel oncolytic viruses.
Enquyst Technologies
enquyst.com
Enquyst Technologies is an engineering next-generation purification technologies which will disrupt the way biological drugs are developed.
Evivue Technologies
Evivue Technologies has a differentiated and proprietary drug delivery technology platform and will create a pipeline of 505b2 FDA approved, topically applied products for hair loss.
Hopkins MedTech Group LLC dba HopkinsMedtechCompliance
HMC Research and Clinical Lab is an independent diagnostic lab founded by Hopkins MedTech.
Innovative Molecules
Innovative Molecules is a drug discovery and contract research services company that will apply organic chemistry and biochemistry to optimize the pharmacotherapeutic utility of medicinal compounds. The company’s development programs intend to yield novel compounds with low risk and high payoff. The company will target novel compounds comprise of metabolites, prodrugs, and analogues of approved medicines or natural compounds with known pharmacological activity.
LACTIGA
lactiga.com
Lactiga™ is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. Lactiga is unlocking the full therapeutic value of human milk to create the next generation of anti-infectives that can battle even the world’s most dangerous pathogens.
Linus Biotechnology Inc.
linusbio.com
LinusBio is a patient-centric, precision exposome medicine company.
Originating from the world’s leading exposome laboratory at Mount Sinai Health System, Linus has developed a technology platform that builds on breakthroughs in exposome sequencing by trailblazing researchers Drs. Manish Arora, Christine Austin and Paul Curtin.
The Company’s program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.
Neoventech
neoventech.com
Neoventech strives to be the recognized leader in topical drug and active cosmetic product development. Our dedicated R&D team has a combined of 70+ years’ experience in drug delivery, cosmetic and topical drug product development and their successful global commercialization. The mission is to assist you to transform innovative ideas into successful cosmetics or topicalpharmaceutical products to address the dermatological disorders and unmet consumer needs in skin health. Neoventech commits to partner with industrial leaders and to find better ways to deliver the high quality products and services in a timely manner.
OLI Technologies
OLI Technologies is revolutionizing end-stage renal disease treatment. Leveraging proprietary nanotechnologies, OLI is developing intelligent wearables that emulate the natural capabilities of healthy kidneys.
PolyGone Systems
PolyGone Systems was co-founded in 2021 by Princeton Grads and Forbes 30 Under 30 fellows Nathaniel Banks & Yidian Liu in response to the global inaction in addressing escalating microplastic contamination levels. Specifically, the duo noted that while systems exist for the collection and recycling for large plastic items, none exist for intercepting, collecting and recycling microplastics. PolyGone was formed to bridge this gap by developing and deploying critical infrastructure for microplastic interception and recovery.
Skunkworx Labs
Skunkworx Labs (SKWX) is an innovative biologic drug discovery company dedicated to creating therapeutics targeting cancer, inflammation, and infectious diseases. Our unique protein screening platforms provide greater combinatory diversity than what naturally occurs in nature. It reaches beyond visible biology producing truly synthetic possibilities. SKWX serves to fix biological problems by providing synthetic solutions through its NanoProtein and NanoAntibody Libraries. Skunkworx can generate candidate biologics from known and unknown targets, identify new targets and generate tools and agents to guide rational drug design.
SHINKEI Therapeutics
Shinkei (shinkeitherapeutics.com)
Shinkei is a clinical stage CNS (Central Nervous System) disorders focused pharmaceutical company using the 505(b)2 regulatory strategy to repurpose existing pharmaceutical products for faster and better patient outcome. Th company has a diversified and robust product development pipeline.
Venora Pharma
Venora is precision oncology company developing small molecule therapies.
Zena Therapeutics
An innovative drug discovery company focused on patient safety.
Zena is a women-led team working on developing new drugs to treat alcohol and substance use as well as anxiety disorders. Zena aims to mitigate the harmful impacts of poly-substance use and prevent future overdose fatalities. The team’s expertise ranges from medicinal to natural-products chemistry.
